MAPT and Alzheimer disease: A number of studies have shown that mTORC1 activity is increased in the brains of mice and humans with AD, and previous studies have demonstrated that mTORC1 activity is positively correlated with tau phosphorylation38,88, suggesting a role for increased mTORC1 signaling in the etiology of AD.